Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]
Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]. // Mayo Clinic Proceedings: Innovations, Quality & Outcomes. – URL: https://www.sciencedirect.com/science/article/pii/S2542454826000822?dgcid=rss_sd_all
Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. https://www.sciencedirect.com/science/article/pii/S2542454826000822?dgcid=rss_sd_all
“Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755].” Mayo Clinic Proceedings: Innovations, Quality & Outcomes.
@article{article57761,
title = {Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality \& Outcomes 10(5) (2026) PIQO\_100755]},
journal = {Mayo Clinic Proceedings: Innovations, Quality \& Outcomes},
url = {https://www.sciencedirect.com/science/article/pii/S2542454826000822?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...